# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Hereditary von Willebrand Disease
- **MONDO ID:**  (if available)
- **Category:** Genetic

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Hereditary von Willebrand Disease**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-01-31T17:08:39.447627

1. parnian2024mechanismandconsequences pages 157-159
2. karampini2024oglycandeterminantsregulate pages 12-13
3. moser2024progressinvon pages 1-1
4. du2023vonwillebranddisease pages 9-10
5. saadalla2023vonwillebrandfactor pages 1-1
6. seidizadeh2023populationbasedprevalenceand pages 2-5
7. seidizadeh2026updatedglobalprevalence pages 1-5
8. seidizadeh2026updatedglobalprevalence pages 15-19
9. seidizadeh2025globalprevalenceand pages 6-8
10. seidizadeh2025globalprevalenceand pages 4-6
11. seidizadeh2025globalprevalenceand pages 1-4
12. seidizadeh2026updatedglobalprevalence pages 5-10
13. https://doi.org/10.1182/bloodadvances.2023012499
14. https://doi.org/10.7939/r3-8e39-4057
15. https://doi.org/10.1038/s41525-023-00375-8
16. https://doi.org/10.1038/s41598-026-36145-6
17. https://doi.org/10.2147/JBM.S389241
18. https://doi.org/10.1055/s-0044-1779485
19. https://doi.org/10.1055/s-0042-1757183
20. https://doi.org/10.1182/bloodadvances.2023012499,
21. https://doi.org/10.7939/r3-8e39-4057,
22. https://doi.org/10.1038/s41598-026-36145-6,
23. https://doi.org/10.1055/s-0044-1779485,
24. https://doi.org/10.2147/jbm.s389241,
25. https://doi.org/10.21203/rs.3.rs-6577209/v1,
26. https://doi.org/10.1055/s-0042-1757183,
27. https://doi.org/10.1038/s41525-023-00375-8,